H P Rhodes, MD in Bedford, VA - Radiology

H P Rhodes, MD is a Radiology - Diagnostic Radiology physician based in Bedford, Virginia. H P Rhodes is licensed to practice in Virginia (license number 0101018377) and his current practice location is 1613 Oakwood Street, Bedford, Bedford, Virginia. He can be reached at his office (for appointments etc.) via phone at (540) 587-3245.

NPI number for H P Rhodes is 1053393090 and his current mailing address is 202 N Branch Rd, Bedford, Bedford, Virginia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1053393090.

Contact Information

	H P Rhodes, MD
	1613 Oakwood Street, Bedford, Bedford, VA 24523-1213
	(540) 587-3245
	(540) 586-0317

Physician's Profile

Full Name	H P Rhodes
Gender	Male
Speciality	Radiology - Diagnostic Radiology
Location	1613 Oakwood Street, Bedford, Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1053393090
Provider Enumeration Date: 11/16/2005
Last Update Date: 10/08/2008

Medical Identifiers

Medical identifiers for H P Rhodes such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053393090	NPI	-	NPPES
007241810	Medicaid	VA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2085R0202X	Radiology - Diagnostic Radiology	0101018377 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. H P Rhodes is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
H P Rhodes, MD 202 N Branch Rd, Bedford, Bedford, VA 24523-1240 Ph: (540) 586-3300	H P Rhodes, MD 1613 Oakwood Street, Bedford, Bedford, VA 24523-1213 Ph: (540) 587-3245

News Archive

Congenital anomaly clusters may be going undetected in UK

A lack of national surveillance of congenital anomalies in England and Wales may lead to clusters of congenital conditions going unnoticed, say UK researchers.

White House report says health reform will cut cost growth

The New York Times: The chair of the White House Council of Economics Advisers said Monday that the Senate health care reform bill would slow the grown of spending by 1 percent each year. "I want to tell you that what's going on on the floor of the Senate right now is probably the most important thing we can do for the long run fiscal health of this country," said Christina Romer, according to the Times.

Discovery brings embryonic stem cell medicine a step closer

A team of scientists announced a critical step on the path of realizing the promise of embryonic stem (ES) cells for medicine. The researchers have discovered unique molecular imprints coupled to DNA in mouse ES cells that help explain the cells' rare ability to form almost any body cell type. These imprints, or "signatures," appear near the master genes that control embryonic development and probably coordinate their activity in the early stages of cell differentiation. Not only do these findings help to unlock the basis for ES cells' seemingly unlimited potential, they also suggest ways to understand why ordinary cells are so limited in their abilities to repair or replace damaged cells.

U.N. officials warn Yemen facing humanitarian, health disasters

High-level officials from UNICEF and the World Food Programme (WFP) this week warned that "routine immunization of children has dropped by 40 percent in some areas of Yemen, leading to outbreaks of polio and measles and reflecting a growing collapse of public services in a country that is on the brink of a humanitarian disaster," IRIN reports.

'Turkey tail' mushroom effectively suppresses prostate tumour development

A mushroom used in Asia for its medicinal benefits has been found to be 100 per cent effective in suppressing prostate tumour development in mice during early trials, new Queensland University of Technology (QUT) research shows.

H P Rhodes, MD - Radiology in Bedford, VA